Last A$0.04 AUD
Change Today +0.001 / 2.86%
Volume 169.6K
PRR On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ GM
Xetra
As of 9:16 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for prima biomed ltd (PRR)

Year over year, Prima Biomed Ltd. has been able to grow revenues from A$1.6M AUD to A$2.0M AUD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold, SGA expenses and income tax expenses. These changes narrowed bottom line losses from A$15.2M AUD to A$13.3M AUD.
View Income Statement In U.S. Dollar
Currency in
Millions of Australian Dollars
As of:Jun 30
2011
Restated
AUD
Jun 30
2012
Reclassified
AUD
Jun 30
2013
AUD
Jun 30
2014
AUD
4 Year
Trend
Revenues--1.51.62.0
TOTAL REVENUES--1.51.62.0
Cost of Goods Sold9.515.114.011.9
GROSS PROFIT-9.5-13.6-12.4-9.9
Selling General & Admin Expenses, Total5.66.04.94.1
Depreciation & Amortization, Total0.10.20.30.4
OTHER OPERATING EXPENSES, TOTAL5.76.25.14.5
OPERATING INCOME-15.2-19.8-17.5-14.4
Interest Expense-6.4------
Interest and Investment Income1.12.70.90.7
NET INTEREST EXPENSE-5.32.70.90.7
Currency Exchange Gains (Loss)---2.71.40.4
EBT, EXCLUDING UNUSUAL ITEMS-20.5-19.8-15.1-13.3
Gain (Loss) on Sale of Investments-0.6------
Other Unusual Items, Total---0.2----
EBT, INCLUDING UNUSUAL ITEMS-21.1-19.9-15.1-13.3
Income Tax Expense----0.10.0
Minority Interest in Earnings0.0------
Earnings from Continuing Operations-21.1-19.9-15.2-13.3
NET INCOME-21.1-19.9-15.2-13.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-21.1-19.9-15.2-13.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-21.1-19.9-15.2-13.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRR:AU A$0.04 AUD +0.001

PRR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRR.
View Industry Companies
 

Industry Analysis

PRR

Industry Average

Valuation PRR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.8x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRIMA BIOMED LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.